Hanmi’s 4 products including ‘Amosartan 5/50mg’ manufactured worth of KRW 67.2 billion

The last year’s total manufactured amount of products which were approved as an incrementally modified drug was KRW 184.2 billion, and the Hanmi Pharm’s 4 products including ‘Amosartan 5/50mg’ were recorded at KRW 67.2 billion in the category.

According to the 2015 pharmaceutical manufacturing performance aggregated by the Ministry of Food and Drug Safety(MFDS), the total manufacturing perfor...